Die systemische therapie im behandlungskonzept des atopischen ekzems. Bewahrte behandlungsverfahren und experimentelle entwicklungen

Translated title of the contribution: Systemic agents in the therapeutic approach to atopic eczema. Established treatments and experimental developments

Knut Brockow, Dietrich Abeck, Johannes Ring

Research output: Contribution to journalReview articlepeer-review

7 Scopus citations

Abstract

Our therapeutic approach to atopic eczema consists of a continous topical dermatological basic therapy in combination with an antiinflammatory therapy in phases of exacerbations. In the treatment of exacerbated atopic eczema, systemic agents are added to achieve effective control more rapidly or to induce remissions in cases refractory to standard therapy. Antihistamines to control the pruritus, as well as antibiotics and acyclovir for antimicrobial superinfections are often used. In many patients exacerbations can be successfully controlled with phototherapy, especially with UVA1 light. The use of systemic immunosuppressants, like glucocorticosteroids, cyclosporine or azathioprine generally can be avoided and is a therapeutic alternative only in few selected cases. In the last years promising new experimental treatments have evolved, which could become therapeutic alternatives for the future.

Translated title of the contributionSystemic agents in the therapeutic approach to atopic eczema. Established treatments and experimental developments
Original languageGerman
Pages (from-to)323-329
Number of pages7
JournalHautarzt
Volume50
Issue number5
DOIs
StatePublished - May 1999
Externally publishedYes

Fingerprint

Dive into the research topics of 'Systemic agents in the therapeutic approach to atopic eczema. Established treatments and experimental developments'. Together they form a unique fingerprint.

Cite this